Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Medtronic and Somnus to codevelop snoring and sleep apnea therapy

April 25, 1997

Merck KGaA describes PDE IV inhibitors

April 24, 1997

Agouron and Nastech to develop common cold treatment

April 22, 1997

Dyax and Debiopharm collaborate to develop treatments for pulmonary disorders

April 21, 1997

Alliance temporarily suspends enrollment in its LiquiVent clinical trial

April 21, 1997

Rhone-Poulenc Rorer's ebastine now available in The Netherlands

April 17, 1997

New cell adhesion inhibitor from Biogen

April 17, 1997

Dual TxA2/LT receptor antagonist selected for development by Yamanouchi

April 17, 1997

Biogen reveals new cell adhesion inhibitor

April 16, 1997

Schering-Plough's Nasonex approved in U.K. and France

April 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...